| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Departments of Obstetrics and Gynecology [J. R. L., A. W. O., L. T., Y. J., Y. Z., H. T.], and Pathology [G. N.], University of Michigan Medical School, Ann Arbor, Michigan 48109
Alterations in the regulation of apoptosis may contribute to the pathogenesis of cancer and resistance of tumor cells to chemotherapy. In mammalian cells, nonreceptor-mediated apoptosis occurs predominantly via assembly of a cytochrome c-dependent apoptosome complex containing caspase-9 and apoptotic protease-activating factor-1 (Apaf-1). We show here that cytosolic extracts from human ovarian carcinoma cell lines and primary ovarian tumor samples are deficient in their ability to activate procaspase-9 in the presence of cytochrome c and dATP when compared with control extracts. SKOV3, a human ovarian carcinoma cell line with diminished apoptosome activity, was significantly more resistant to chemotherapy-induced apoptosis than cell lines with functional Apaf-1 activity. This dysfunctional apoptosome activity was not explained by reduced expression levels of caspase-9 or Apaf-1. Moreover, expression levels of known inhibitors of the apoptosome, including heat shock protein 70, heat shock protein 90, or X-linked inhibitor of apoptosis, did not correlate with functional activity of the apoptosome. SKOV3, an ovarian cancer cell line with dysfunctional apoptosome activity, retains the ability to form the Apaf-1 oligomer; however, there is a diminished amount of caspase-9 in the apoptosome. The reduction in the amount of caspase-9 in the apoptosome in the SKOV3 cell line was associated with diminished caspase-3 activity. Dysfunctional apoptosome activation may contribute both to the pathogenesis of ovarian carcinoma and to chemoresistance.
This article has been cited by other articles:
|
|
 |
|
  V. J. Lavallard, L. A. Pradelli, A. Paul, M. Beneteau, A. Jacquel, P. Auberger, and J.-E. Ricci Modulation of Caspase-Independent Cell Death Leads to Resensitization of Imatinib Mesylate-Resistant Cells Cancer Res., April 1, 2009; 69(7): 3013 - 3020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Zhong, Y.-J. Wen, H.-S. Yang, H. Luo, A.-F. Fu, F. Yang, L.-J. Chen, X. Chen, X.-R. Qi, H.-G. Lin, et al. Efficient inhibition of cisplatin-resistant human ovarian cancer growth and prolonged survival by gene transferred vesicular stomatitis virus matrix protein in nude mice Ann. Onc., September 1, 2008; 19(9): 1584 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Muscolini, R. Cianfrocca, A. Sajeva, S. Mozzetti, G. Ferrandina, A. Costanzo, and L. Tuosto Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells Mol. Cancer Ther., June 1, 2008; 7(6): 1410 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gaither, D. Porter, Y. Yao, J. Borawski, G. Yang, J. Donovan, D. Sage, J. Slisz, M. Tran, C. Straub, et al. A Smac Mimetic Rescue Screen Reveals Roles for Inhibitor of Apoptosis Proteins in Tumor Necrosis Factor-{alpha} Signaling Cancer Res., December 15, 2007; 67(24): 11493 - 11498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. T. Schafer, A. B. Parrish, K. M. Wright, S. S. Margolis, J. R. Marks, M. Deshmukh, and S. Kornbluth Enhanced Sensitivity to Cytochrome c-Induced Apoptosis Mediated by PHAPI in Breast Cancer Cells Cancer Res., February 15, 2006; 66(4): 2210 - 2218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sun, S. Orrenius, S. Pervaiz, and B. Fadeel Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance Blood, May 15, 2005; 105(10): 4070 - 4077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Chen, Y. Pengetnze, and C. C. Taylor Src inhibition enhances paclitaxel cytotoxicity in ovarian cancer cells by caspase-9-independent activation of caspase-3 Mol. Cancer Ther., February 1, 2005; 4(2): 217 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Deming, Z. T. Schafer, J. S. Tashker, M. B. Potts, M. Deshmukh, and S. Kornbluth Bcr-Abl-Mediated Protection from Apoptosis Downstream of Mitochondrial Cytochrome c Release Mol. Cell. Biol., December 1, 2004; 24(23): 10289 - 10299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zanon, A. Piris, I. Bersani, C. Vegetti, A. Molla, A. Scarito, and A. Anichini Apoptosis Protease Activator Protein-1 Expression Is Dispensable for Response of Human Melanoma Cells to Distinct Proapoptotic Agents Cancer Res., October 15, 2004; 64(20): 7386 - 7394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Besse, C. Cande, J.-P. Spano, A. Martin, D. Khayat, T. Le Chevalier, T. Tursz, L. Sabatier, J.-C. Soria, and G. Kroemer Nuclear Localization of Apoptosis Protease Activating Factor-1 Predicts Survival after Tumor Resection in Early-Stage Non-Small Cell Lung Cancer Clin. Cancer Res., September 1, 2004; 10(17): 5665 - 5669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mezzanzanica, E. Balladore, F. Turatti, E. Luison, P. Alberti, M. Bagnoli, M. Figini, A. Mazzoni, F. Raspagliesi, M. Oggionni, et al. CD95-Mediated Apoptosis Is Impaired at Receptor Level by Cellular FLICE-Inhibitory Protein (Long Form) in Wild-Type p53 Human Ovarian Carcinoma Clin. Cancer Res., August 1, 2004; 10(15): 5202 - 5214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Gifford, J. Paul, P. A. Vasey, S. B. Kaye, and R. Brown The Acquisition of hMLH1 Methylation in Plasma DNA after Chemotherapy Predicts Poor Survival for Ovarian Cancer Patients Clin. Cancer Res., July 1, 2004; 10(13): 4420 - 4426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Opipari Jr., L. Tan, A. E. Boitano, D. R. Sorenson, A. Aurora, and J. R. Liu Resveratrol-induced Autophagocytosis in Ovarian Cancer Cells Cancer Res., January 15, 2004; 64(2): 696 - 703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. E. Pardo, A. Lesay, A. Arcaro, R. Lopes, B. L. Ng, P. H. Warne, I. A. McNeish, T. D. Tetley, N. R. Lemoine, H. Mehmet, et al. Fibroblast Growth Factor 2-Mediated Translational Control of IAPs Blocks Mitochondrial Release of Smac/DIABLO and Apoptosis in Small Cell Lung Cancer Cells Mol. Cell. Biol., November 1, 2003; 23(21): 7600 - 7610. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Belmokhtar, J. Hillion, C. Dudognon, S. Fiorentino, M. Flexor, M. Lanotte, and E. Segal-Bendirdjian Apoptosome-independent Pathway for Apoptosis: BIOCHEMICAL ANALYSIS OF APAF-1 DEFECTS AND BIOLOGICAL OUTCOMES J. Biol. Chem., August 8, 2003; 278(32): 29571 - 29580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Nguyen and J. A. Wells Direct activation of the apoptosis machinery as a mechanism to target cancer cells PNAS, June 24, 2003; 100(13): 7533 - 7538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Henderson, M. Mizzau, G. Paroni, R. Maestro, C. Schneider, and C. Brancolini Role of Caspases, Bid, and p53 in the Apoptotic Response Triggered by Histone Deacetylase Inhibitors Trichostatin-A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) J. Biol. Chem., March 28, 2003; 278(14): 12579 - 12589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Yang, T. Mashima, S. Sato, M. Mochizuki, H. Sakamoto, T. Yamori, T. Oh-hara, and T. Tsuruo Predominant Suppression of Apoptosome by Inhibitor of Apoptosis Protein in Non-Small Cell Lung Cancer H460 Cells: Therapeutic Effect of a Novel Polyarginine-conjugated Smac Peptide Cancer Res., February 15, 2003; 63(4): 831 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mueller, W. Voigt, H. Simon, A. Fruehauf, A. Bulankin, A. Grothey, and H.-J. Schmoll Failure of Activation of Caspase-9 Induces a Higher Threshold for Apoptosis and Cisplatin Resistance in Testicular Cancer Cancer Res., January 15, 2003; 63(2): 513 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Belov, L. I. Romanova, E. A. Tolskaya, M. S. Kolesnikova, Y. A. Lazebnik, and V. I. Agol The Major Apoptotic Pathway Activated and Suppressed by Poliovirus J. Virol., December 6, 2002; 77(1): 45 - 56. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Crowley-Weber, C. M. Payne, M. Gleason-Guzman, G. S. Watts, B. Futscher, C. N. Waltmire, C. Crowley, K. Dvorakova, C. Bernstein, M. Craven, et al. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate Carcinogenesis, December 1, 2002; 23(12): 2063 - 2080. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
